Description
The Use of Genetically-Enhanced Saccharomyces Cerevisiae
Amendment chain · 1 entry
Each notch is one published row for this agreement: #0 is the original (placed at its start date) and each later notch is an amendment (placed at its amendment date). The height is the agreement's total value as of that row — the source column is cumulative, not a change amount — so the line reads as the commitment over time and the right-most notch is the current commitment shown in the header.
- #02008-03-11$1,750,400
| Row | Date | Total value as of row | Change vs previous | Description on this row |
|---|---|---|---|---|
| #0 original | 2008-03-11(start date) | $1,750,400 | — | The Use of Genetically-Enhanced Saccharomyces Cerevisiae |
Related records · 5
Records are related by an explicit link in the data, stated for each group below — never by text similarity. Values are each agreement's current commitment (latest amendment).
Other recipients funded under "Atlantic Innovation Fund (AIF) - II" by Atlantic Canada Opportunities Agency | Agence de promotion économique du Canada atlantique (most recent first)
| Ref | Recipient | Fiscal year | Current value | FY |
|---|---|---|---|---|
| 276-2019-2020-Q4-00166 | Canadian Health Solutions Inc.|Canadian Health Solutions Inc. | FY2020 | $3,000,000 | FY2020 |
| 276-2019-2020-Q4-00153 | The University of New Brunswick|The University of New Brunswick | FY2020 | $6,686,010 | FY2020 |
| 276-2019-2020-Q4-00303 | Springboard Atlantic Inc.|Springboard Atlantic Inc. | FY2020 | $9,559,152 | FY2020 |
| 276-2019-2020-Q2-00594 | Fugro Canada Corp.|Fugro Canada Corp. | FY2020 | $942,444 | FY2020 |
| 276-2019-2020-Q2-00566 | Fugro Canada Corp.|Fugro Canada Corp. | FY2020 | $1,575,000 | FY2020 |
Cite as: Glassbox record view · Federal grants & contributions · 276-2007-2008-Q4-00140 · retrieved 2026-11-13.